Case Report of Open Journal of Gastroenterology and Hepatology
Kayexalate or Kalimate crystals: are they the culprits or the bystanders?
Chen Fang Hsu, Swei H Tsung
Department of Pathology, St Mary Hospital, Loudong, Yilan, Taiwan
Sodium polystyrene sulfonate (Kayexalate) or its analog calcium polystyrene sulfonate (Kalimate) has long been used to treat hyperkalemia in patients with chronic kidney disease (CKD). Although the side effect was rare, there were many case reports in the literature. Its etiology remains unclear. Lillemoe et al., on five uremic patients who developed catastrophic colonic necrosis that was temporally associated with the use of Kayexalate in sorbitol, contributed to death in four of their patients. They further provided experimental evidence implicating sorbitol as the agent responsible for colonic necrosis in a rat model. In contrast to the results of aforementioned animal study, Ayoub et al., published another experimental study in rats, they demonstrated that sodium polystyrene sulfonate (SPS), not sorbitol, was the main culprit for colonic necrosis. Recently, we encountered three patients who had hyperkalemia and were on Kalimate in water. They underwent colonic and gastric biopsy because of developing gastrointestinal symptoms. Kalimate crystals were found in all biopsy specimen, admixed with inflammatory exudate, or standing along on the mucosa surface, without provoking inflammatory reaction. We reviewed the photographs in the published case reports, they were similar to ours. Therefore, we felt that those crystals were bystanders, not the culprits. We fell that SPS ion-exchange resins, if given in water, appears to be clinically effective and reasonably safe to treat hyperkalemia in patients with CKD.
Keywords: Kayexalate, kalimate, hyperkalemia, chronic kidney disease, side effect.
How to cite this article:
Chen Fang Hsu, Swei H Tsung.Kayexalate or Kalimate crystals: are they the culprits or the bystanders? .Open Journal of Gastroenterology and Hepatology, 2020, 3:28. DOI: 10.28933/ojgh-2019-12-0205
1. Arvanitakis C, Malek G, Uehling D, Morrissey JF. Colonic complication after renal transplantation. Gastroenterology 1973; 64;533-538.
2. Rashid A, Hamilton S: Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate [Kayexalate] in sorbitol: An underrecognized condition. Am J Surg Pathol 1997;21: 50-69.
3. Abraham SC, Bhagavan BS, Lee LA, Rashid A, Wu TT: Upper gastrointestinal tract in patients receiving Kayxalate [ sodium polystyrene sulfonate] in sorbitol. Am J Surg Pathol 2001; 25:637-644.
4. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, William GM: Intestinal necrosis due to sodium polystyrene[Kayexalate] in sorbitol enema: Clinical and experimental support for the hypothesis: Surgery 1987 101:267-272,
5. Ayoub I, Oh MS, Gupta R, McFarlane M, Baniska A, Salifu O. Colonic necrosis due to sodium polystyrene sulfonate with and without sorbitol: An experimental study in rats. PLOS ONE 10 : September 28 2015 e0137636.doi:10.1371/journal.pone.0137636
6. Scherr L, Ogden DA, Mead AW, Spritz N, Rubin LA. Management of hyperkalemia with a cation-exchange resin. N Engl J Med 1961; 264:115-119.
7. Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM. Gastrointestinal adverse events with sodium polystyrene sulfonate [Kayexalate] use: A systematic review. Am J of Med 2013;126: 263e9-264e24.
8. Watson MA, Baker TP, Nguyen A, Sebastianelli ME, Stewart HL, Oliver DK, et al. Abbott KC, Yuan CM : Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: A retrospective cohort study. Am J Kidney Dis 2012; 60; 409-416.
9. Sterns RH, Rojas M, Bernstein P, Chennupati S: Ion-Exchange resins for the treatment of hyperkalemia: Are they safe and effective? J Am Soc Nephrol 2010;21:733-735.
10. Watson M, Abbott KC, Yuan CM: Damned if you Do, Damned if you don’t: Potassium binding resins in hyperkelamia: J Am Soc Nephrol 2010; 5:1723-1726,
This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.